Why does this page look this way?
It appears that you are using either an older, classic Web browser or a hand-held device that allows you to view our content but may not work with every feature of our site. If you are using an older browser, please upgrade for the best experience.
Navigation
home > by publication type > backgrounders > Anthrax
Updated: January 2006
This Q&A fact sheet addresses many common questions about anthrax. It is not a substitute for hands-on medical treatment. If you have a personal health concern, you should consult a physician.
Anthrax is a bacteria found naturally in soil as close to home as rural Texas, Oklahoma, and near the Mississippi River. Anthrax is also made in research and military labs. The scientific name for Anthrax is Bacillus anthracis.
Usually, they don’t. Most of what we know about anthrax comes from studying infected animals. In humans, natural cases of anthrax poisoning are very rare and are primarily a hazard for tanners, veterinarians, and other workers exposed to infected animals or animal parts. Not everyone exposed to anthrax contracts the disease.
There are three forms of Anthrax. They correspond to how it enters the body:
It depends on the strain of anthrax, how it’s contracted, and the age and health of the victim.
No. According to the Centers for Disease Control and Prevention, you can’t get it from someone who coughs next to you.
Symptoms differ depending on how the disease is contracted:
A year after the fall 2001 anthrax letters, many of those infected were still suffering from symptoms including fatigue, shortness of breath, chest pains, and memory loss. The National Institutes of Health are planning a comparative study of the victims to learn more about the disease’s longer-term effects.
With antibiotics. Cipro is by far the best known, but penicillin and doxycycline have also been effective treating the forms contracted in the mailed letters. A May 2002 study said a treatment involving shots of vaccine plus a sixty-day regimen of several antibiotics is more effective than simply taking Cipro.
Scientists say a special enzyme developed by Rockefeller University biologists may also be an effective antidote, if injected quickly after the disease is contracted. But experts say that many more tests must be completed before the enzyme can be used as a drug.
Probably. There are ways to modify anthrax genes to render the bacteria resistant to antibiotics.
Weigh in on this issue by emailing CFR.org.
To order Task Force reports, Council Special Reports, and Critical Policy Choices, please call, fax, or order online from our distributor, the Brookings Institution Press: phone +1.800.537.5487, fax +1.410.516.6998.
For information on other reports that are not for sale, or for general publications information, please call +1.212.434.9516 or email publications@cfr.org.
Start-Up Nation addresses the trillion-dollar question: How is it that Israel—a country of 7.1 million, only sixty years old, surrounded by enemies— produces more start-up companies than large, peaceful, and stable nations like Japan, China, India, Korea, Canada, and the UK? With the insights of geopolitical experts and investors, the authors examine this nation’s adversity-driven culture to answer this question and offer prescriptions for a global economy on the rebound.
In Forces of Fortune, Vali Nasr presents a paradigm-changing revelation that will transform the understanding of the Muslim world at large. He reveals that there is a vital but unseen rising force in the Islamic world—a new business-minded middle class—that is building a vibrant new Muslim world economy and that holds the key to winning the cold war against Iran and extremists.
In Cuba: What Everyone Needs to Know, Julia E. Sweig presents a remarkably accessible portrait of Cuba's unique place on the world stage over the past fifty years, including its internal politics, its often fraught relationship with the United States, and its shifting relationship with the global community.
Complete list of CFR Books
The report of this bipartisan Task Force of distinguished leaders and experts represents a strong consensus on the importance of repairing America's immigration policy. It makes the case that maintaining America's political and economic leadership depends on attracting talented and hard-working immigrants, and on securing the country's borders in a smart, effective, and humane way.
This report finds that nuclear weapons will remain a fundamental element of U.S. national security in the near term, and makes recommendations on how to ensure the safety, security, and reliability of the U.S. deterrent nuclear force, prevent nuclear terrorism, and strengthen the nuclear nonproliferation regime.
About Independent Task Forces at CFR
Complete list of Task Force reports
Identifying international threats and acting on them may be the most difficult job for U.S. policymakers. This report
provides an actionable road map for managing international threats before they erupt into crises and makes a strong case that preventive action is not a luxury but a necessity.
For more than a decade, the United States has mostly watched from the sidelines as Asian countries organize themselves into an alphabet soup of new multilateral groups. In this report, the authors review the relationship between pan-Asian and trans-Pacific institutions and suggest policy guidelines for a new U.S. approach to this new Asian landscape.
Complete list of Council Special Reports
To request permission to reprint or reuse CFR material, please fill out this permissions request form (PDF), referring to the instructions on page 1.
Browse Content By Region IssuePublication TypeThe Think TankFor The MediaFor Educators About CFR
Copyright 2009 by the Council on Foreign Relations. All Rights Reserved.
